PF-06409577 is a selective androgen receptor modulator (SARM) investigated for its potential to address muscle wasting and sarcopenia. By selectively targeting androgen receptors in skeletal muscle tissue,… Read more
PF-06409577 is a selective androgen receptor modulator (SARM) investigated for its potential to address muscle wasting and sarcopenia. By selectively targeting androgen receptors in skeletal muscle tissue, this compound aims to promote muscle health while minimizing androgenic effects in other organ systems. This category features the parent compound alongside key metabolites, such as the acyl glucuronide, and a range of stable isotope labelled internal standards. Pharmaceutical and clinical laboratories rely on these high-quality reference materials to support robust impurity profiling, method validation, and quantitative bioanalysis. The inclusion of deuterated analogs, such as d4 and d8 versions, provides essential tools for ensuring precision in liquid chromatography-mass spectrometry (LC-MS) assays, allowing researchers to accurately monitor drug stability and metabolic pathways during rigorous quality control and preclinical development processes.